Home  >  News
News
  MorphoSys L-MIND phase 2 trial of tafasitamab in combo with lenalidomide meets primary endpoint,   May 20, 2019
  Allergan expands PLEDGE clinical programme to evaluate relamorelin for diabetic gastroparesis treatment,   May 20, 2019
  Rigel enrolls first patient in phase 3 clinical trial of Fostamatinib Disodium Hexahydrate in warm autoimmune hemolytic anemia,   May 18, 2019
  Axovant begins clinical study of AXO-AAV-GM1, a novel gene therapy to treat GM1 gangliosidosis,   May 18, 2019
  Atriva Therapeutics begins patient dosing in phase 1 trial of ATR-002 to treat influenza virus infections,   May 18, 2019
  GlaxoSmithKline to present 70 abstracts ATS 2019,   May 17, 2019
  4D pharma to present phase Ib study data on Thetanix to treat Crohn's disease at DDW meeting,   May 17, 2019
  HDL Therapeutics announces positive data from registration trial of PDS-2 System in homozygous familial hypercholesterolemia,   May 17, 2019
  AstraZeneca to present oncology portfolio, including data of cancer medicines Lynparza & Imfinz at the 2019 ASCO annual meeting,   May 17, 2019
  Roche to present positive data from phase I/II STARTRK-NG study of entrectinib at ASCO annual meeting,   May 17, 2019
  Biocon and Mylan to present final survival data for Ogivri at ASCO meeting on June 3,   May 16, 2019
  Myovant Sciences' phase 3 LIBERTY 1 study of once daily relugolix combo therapy in women with uterine fibroids meets endpoints,   May 16, 2019
  Modus Therapeutics phase 2 trial of sevuparin for management of acute VOC in patients with SCD fails to meet endpoint,   May 15, 2019
  Centogene initiates two year global study to investigate genetic factors in Parkinson’s disease,   May 15, 2019
  Transgene receives US FDA nod to begin phase 1 trial of lead myvac candidate, TG4050 to treat ovarian cancer,   May 15, 2019
  Medivir presents positive data from remetinostat phase II study in basal cell carcinoma at SID meeting,   May 14, 2019
  ReGenTree begins ARISE-3 phase 3 trial for dry eye syndrome,   May 14, 2019
  Merck announces positive results from phase II study of evobrutinib in patients with elapsing multiple sclerosis,   May 13, 2019
  Scancell appoints 6 clinical oncologists to guide Moditope clinical development strategy, provides update on Modi-1,   May 13, 2019
  New phase 2b analysis suggests AEROSURF may reduce incidence and severity of BPD in preterm infants with RDS,   May 13, 2019

 Back
 
IPJ_2019_pharmabiz_150x60
Ipe_2019_150x 60
CPhI_Korea_2019_150x60
PharmaLytica150x60_2019
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |